Malignant Hyperthermia VR

Simulation demonstrates a patient experiencing malignant hyperthermia in a realistic operating room environment.

Users learn and practice crucial malignant hyperthermia managements based on MHAUS guidelines configurable to your own institution’s protocols/procedures, including your institution’s specific formulary (e.g., Ryanodex, Revonto, Dantrium).

Simulation provides a virtual, zero-risk environment to practice and learn critical MH management skills.

Est. time to module completion: 20-25 minutes

Target Audience(s): Any health-care provider who would care for patients at risk for developing malignant hyperthermia